logo
Bill aims at eminent domain reform

Bill aims at eminent domain reform

Yahoo22-03-2025

Mar. 21—TOPEKA — A bill has targeted eminent domain laws in Kansas as a Barton County landowner awaits a decision on a taking affecting construction of Grain Belt Express's electric transmission line.
Senate Bill 262, authored and introduced by the Senate Committee on Federal and State Affairs on Feb. 11, was referred to the Committee on Judiciary on Feb. 14. Sen. Tory Marie Blew (R-Great Bend) is the vice-chair of the Affairs Committee.
Sen. Blew was in Topeka Thursday attending a long session on the Senate Floor; after a recess Friday the Senate resumes on Monday at 10 a.m. She explained that her Affairs committee is exempt from certain procedural deadlines.
"Anyone can introduce a bill in any committee, but Fed and State is an exempt committee so the bill never 'dies,'" she said. A hearing on the bill has yet to be scheduled.
The bill in similar form was introduced in the House as HB 2187 by Kansas Rep. Brett Fairchild (R-St. John) on Jan. 31 and referred to the House Committee on Judiciary.
About SB 262
Senate Bill 262 is an extensive revision of K.S.A. 26-501, 502 and 507, which have been on the books since 1963 with some definitions revised in 2007.
As introduced on Feb. 11, 2025, the bill seeks to eliminate the legislature's authority to seize private property for economic development purposes and to narrow the definition of "public use" in eminent domain cases.
One of the key provisions of Senate Bill 262 mandates that any agency intending to acquire private property must provide a good faith offer of compensation to the property owner at least 30 days before filing an eminent domain petition. This offer must be the minimum compensation amount and cannot be reduced or revoked once made.
The bill also prohibits the taking of private property for the purpose of transferring it to a private entity, reinforcing the notion that eminent domain should only be used for public benefit. This change addresses growing concerns among property owners and advocates who argue that previous laws allowed for excessive government overreach in property acquisition. Additionally, of a good faith offer exceeds the appraiser's award, the greater amount may be subject to appeal only by the property owner.
Debate surrounding Senate Bill 262 has been notable, with proponents arguing that it protects property rights and ensures fair compensation for landowners. Critics, however, express concerns that the bill may hinder necessary economic development projects by making it more difficult for agencies to acquire land for public infrastructure or community improvements.
A landowner's support
Tammy Hammond, founder, owner and CEO of Rosewood Services in Barton County, this week submitted written testimony to Sen. Kellie Warren, chair of the Senate Committee on Judiciary to be offered at a future hearing in consideration of the bill.
Currently, Hammond is awaiting the decision of a court-appointed panel of appraisers charged with determination of the contested value of approximately 30 acres of Rosewood Ranch being sought as easement property for Invenergy's Grain Belt Express. GBE plans to construct a 780-mile, 5,000-volt direct current transmission line through Kansas, which includes locating and building several support towers averaging 150 feet in height on four tracts of Rosewood property. After filing a petition invoking eminent domain, GBE and Hammond participated in a condemnation hearing held March 7 and Barton County Courthouse. Along with hearing testimony from witnesses on both sides, the panelists adjourned the hearing to view the Ranch where staked-out locations indicated where the towers were planned to be placed.
In her testimony, Hammond noted that she was "encouraged to see that the current senate bill addresses fair compensation, especially since Invenergy has not compensated landowners adequately. In my own case, the easement agreement is not even written correctly and does not properly describe the prior use of the land for which compensation is being sought.
"I want to make sure that any legislation that is passed cannot simply be circumvented by corporate interest that run counter to the welfare of Kansans. It's crucial that lawmakers understand the future threats to our land, given strategies on the part of private developers to take property for new projects with the encouragement of state and federal governmental agencies."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Associated Press

time2 days ago

  • Associated Press

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ('Silo' or the 'Company'), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset. 'The addition of Bitcoin to our treasury holdings is a strategic decision aimed at diversifying our assets to include a digital store of value with what we believe has significant upside potential,' said Eric Weisblum, CEO of Silo. 'Our purchase of Bitcoin is intended to provide a safeguard against inflation and is expected to position Silo to preserve and optimize long-term shareholder value.' About Silo Pharma Silo Pharma Inc. (Nasdaq: SILO) is a developmental stage biopharmaceutical company focused on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company's portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. Silo's research is conducted in collaboration with leading universities and laboratories. Forward-Looking Statements This news release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified using words 'could', 'believe', 'anticipate', 'intend', 'estimate', 'expect', 'may', 'continue', 'predict', 'potential', and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that could cause the actual results of Silo Pharma, Inc. ('Silo' or 'the Company') to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company's technology platforms, retaining and expanding the Company's customer base, fluctuations in consumer spending on the Company's products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this press release, whether as a result of new information, future events, or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events except as required by law. Contact 800-705-0120 [email protected]

Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal
Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal

Yahoo

time4 days ago

  • Yahoo

Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal

On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for treatment-resistant depression (TRD), generally defined as a failure on two or more antidepressants. Alto paid Chase Therapeutics an upfront payment of $1.75 million. Chase Therapeutics will be eligible for up to $71.5 million in milestone payments, $41 million of the potential future milestone payments are tied to the product candidates' commercial success. Alto expects its current cash balance to support planned operations into 2028 through five clinical trial readouts across its pipeline most advanced program, ALTO-207 (formerly known as CTC-501), is a fixed-dose combination of pramipexole, a dopamine D3-preferring D3/D2 agonist, approved for Parkinson's disease with demonstrated antidepressant effect, and ondansetron, an antiemetic, selective 5-HT3 receptor antagonist. As a fixed-dose combination, ALTO-207 enables rapid titration and higher dosing by mitigating the dose-limiting adverse events typically experienced with pramipexole. Phase 2a trial of CTC-501 Chase Therapeutics completed a Phase 2a trial evaluating CTC-501 in 32 patients with depression. The primary endpoint was achieved in the study. Patients randomized to receive CTC-501 reached a mean dose of 4.1mg per day, with 67% achieving the highest allowable dose of 5mg/day. CTC-501 was generally well tolerated in the maintenance period of the study. CTC-501 demonstrated statistically significant and clinically meaningful improvements from baseline compared to placebo on depression symptoms as measured by the Montgomery Åsberg Depression Rating Scale or MADRS. CTC-501 also demonstrated significantly greater improvement on the Clinician Global Impression Scale of Severity (CGI-S) compared to placebo. Alto expects to initiate a Phase 2b trial, designed to be a potentially pivotal study, with ALTO-207 in patients with TRD by mid-2026 and report topline data in 2027. Phase 2a Trial For CTC-413 ALTO-208 (or CTC-413) is a fixed-dose combination of pramipexole and aprepitant, an antiemetic, neurokinin-1 (NK-1) receptor antagonist. ALTO-208 is being developed for patients with Parkinson's disease (PD). Chase Therapeutics completed a blinded Phase 2a trial evaluating CTC-413 in 13 patients with PD. The mean tolerated dose of CTC-413 significantly exceeded pramipexole. Six subjects (67%) tolerated CTC-413 at the maximum dose of 9.0mg/day, and all but one remained on that dose throughout the final three-month treatment period. CTC-413 demonstrated favorable safety and tolerability with no unexpected, serious or persistent issues. William Blair reiterated an Outperform rating on Alto Neuroscience, viewing the acquisition of ALTO-207 as an 'intriguing asset.' The firm noted the impressive efficacy of pramipexole in the PAX-D study but also highlighted the possibility of functional unblinding in that study, which may have contributed to the perceived efficacy. Price Action: ANRO stock is trading higher by 2.31% to $2.66 at last check Tuesday Read Next:Photo by fizkes via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Calls for delayed West Lothian train station to be funded by Scottish Government
Calls for delayed West Lothian train station to be funded by Scottish Government

Yahoo

time4 days ago

  • Yahoo

Calls for delayed West Lothian train station to be funded by Scottish Government

A veteran councillor in West Lothian called on the Scottish Government to 'put its money where its mouth is' on plans for a railway station in Winchburgh. As the council and Winchburgh Developments prepare to meet potential funders of the long delayed station , Labour's Linlithgow councillor Tom Conn called on the SNP government to 'stop ducking and diving.' Designs were revealed on Friday with the news that a planning application would come to West Lothian Council 'imminently.' READ MORE: Two major roads through Bathgate will see upgrades and resurfacing work A report to the Executive described the recently published Scottish Government Programme for Government 2025/26. It said: 'The programme makes specific reference to a railway station at Winchburgh in the section on A Safe Sustainable Transport System for Scotland.' Having committed to that, Councillor Conn called for a commitment to meet costs of the £22.5m development. Welcoming the news that progression had been made in the ten months of cooperation between the council, Winchburgh developments, Transport Scotland Network Rail - councillors echoed concerns that there have been no concrete guarantees of funding. Councillor Conn said: 'There needs to be public money invested directly by Scottish Government in Winchburgh. They cannot continually suggest it's other people, other organisations that need to find the money. 'This is an abdication of responsibility by the Scottish Government. If they don't want to take responsibility for it, they shouldn't put it in Programme for Government 2025/26. 'The Scottish government needs to stop ducking and diving and need to put their money where their mouth is. This is talking about rail investment strategy. If all it is is words, not backed up with cash, stop speaking. It's not helping.' Fellow Linlithgow councillor Sally Pattle said the progress had been like wading through treacle as she sought clarification of when a business plan could come to the council. When told it would be two to three months she responded: 'I would just like to welcome the fact that the Scottish Government reference Winchburgh in their programme for government although I'm slightly unclear as to what that will mean in practical terms to actually getting this project moving forward. 'I do welcome all the work that has been undertaken collaboratively between key stakeholders since last September but I have to say that still feels like we are moving through treacle. I would also very much like it to be recognised by officers and key stakeholders that the longer this drags on the greater the negative impact it is having on my ward of Linlithgow because of all the commuters that come into use the train station and then park anti-socially across the town to do so so it would be good if that could recognised going forward.' The report detailed passenger usage at neighbouring stations, including Linlithgow which sees 1,400 a day using the station. Gordon Brown, Roads and Transportation Manager told the meeting: 'Progress on the Outline Business Case now allows the steering group to progress discussions with the Scottish Government on the case for investment, alignment with the overall rail strategy, public value and contribution to government priorities. 'These matters will be addressed as part of the funding application subject, of course, to the City Region Deal Joint Committee supporting an application via that route.' The City Region Deal is a mechanism for accelerating growth. It is made up of six local authorities, universities and the private sector working with the Scottish and UK government to pull in investment.' Winchburgh councillor Angela Doran-Timson pressed Mr Brown on what other alternative investment options there would be if the City Region Deal did not agree to fund the station. ' Was there a plan B?" she asked. Mr Brown said there was ' no plan B' but to date 'no alternative funding sources had been identified' Councillor Doran-Timson said: 'I'll echo what Tom Conn said. I welcome the report, fingers crossed that the funding does come forward from the Scottish Government." A spokesperson for Transport Scotland responded by issuing a joint statement issued on behalf of West Lothian Council, Winchburgh Developments Ltd, Transport Scotland, Network Rail and ScotRail which said: 'Further work continues to explore opportunities for innovative construction techniques to support efficient and low-disruption delivery. 'A stakeholder meeting with Minister for Agriculture and Connectivity, Jim Fairlie MSP, is scheduled to take place in Winchburgh on 18 June. This will offer the minister the opportunity to see first-hand the progress made by the project partners.' That same statement contained comments from council leader Lawrence Fitzpatrick: 'It's extremely encouraging to see this project continuing to move forward at pace. With the planning application submitted and business case prepared, we're entering an important phase, which reflects the positive collaboration between all parties." Sign up to Edinburgh Live newsletters for more headlines straight to your inbox

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store